GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AprilBio Co Ltd (XKRX:397030) » Definitions » EV-to-FCF

AprilBio Co (XKRX:397030) EV-to-FCF : -26.51 (As of Jun. 02, 2024)


View and export this data going back to 2022. Start your Free Trial

What is AprilBio Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, AprilBio Co's Enterprise Value is ₩249,626.10 Mil. AprilBio Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-9,416.56 Mil. Therefore, AprilBio Co's EV-to-FCF for today is -26.51.

The historical rank and industry rank for AprilBio Co's EV-to-FCF or its related term are showing as below:

XKRX:397030' s EV-to-FCF Range Over the Past 10 Years
Min: -26.51   Med: -15.47   Max: 11.2
Current: -26.51

During the past 6 years, the highest EV-to-FCF of AprilBio Co was 11.20. The lowest was -26.51. And the median was -15.47.

XKRX:397030's EV-to-FCF is ranked worse than
100% of 377 companies
in the Biotechnology industry
Industry Median: 8.21 vs XKRX:397030: -26.51

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-02), AprilBio Co's stock price is ₩14130.00. AprilBio Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-637.500. Therefore, AprilBio Co's PE Ratio for today is At Loss.


AprilBio Co EV-to-FCF Historical Data

The historical data trend for AprilBio Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AprilBio Co EV-to-FCF Chart

AprilBio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial - - - -17.20 -28.93

AprilBio Co Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.91 -12.71 -16.29 -28.93 -31.64

Competitive Comparison of AprilBio Co's EV-to-FCF

For the Biotechnology subindustry, AprilBio Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AprilBio Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AprilBio Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where AprilBio Co's EV-to-FCF falls into.



AprilBio Co EV-to-FCF Calculation

AprilBio Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=249626.095/-9416.555
=-26.51

AprilBio Co's current Enterprise Value is ₩249,626.10 Mil.
AprilBio Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-9,416.56 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AprilBio Co  (XKRX:397030) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

AprilBio Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=14130.00/-637.500
=At Loss

AprilBio Co's share price for today is ₩14130.00.
AprilBio Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-637.500.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


AprilBio Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of AprilBio Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


AprilBio Co (XKRX:397030) Business Description

Traded in Other Exchanges
N/A
Address
Gangwon University 1, Room 602, Building B, Medical and Bioscience College, Gangwon-daehak-gil (Hyoja-dong), Chuncheon-si, Gangwon-do, KOR
AprilBio Co Ltd is a bio company is developing innovative biologis. It owns long acting protein medicine platform technology utilizing human FAB antobody parts that makes unusual combination to serum akbumin and EX 12 helper phase antibody library technology.

AprilBio Co (XKRX:397030) Headlines

No Headlines